Bruce L Miller Selected Research

Bruce L Miller Research Topics

Disease

126	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 07/2002
72	Frontotemporal Dementia (Semantic Dementia) 12/2023 - 11/2003
61	Dementia (Dementias) 04/2024 - 02/2004
60	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2024 - 03/2004
46	Cognitive Dysfunction 03/2024 - 03/2005
34	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 02/2009
29	Atrophy 01/2024 - 05/2006
26	Tauopathies 01/2024 - 06/2002
16	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 03/2004
15	Corticobasal Degeneration 12/2022 - 06/2008
14	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023 - 10/2006
12	Primary Progressive Aphasia 01/2021 - 10/2008
9	Inflammation (Inflammations) 01/2024 - 11/2011
9	Disease Progression 01/2022 - 02/2008
8	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2019 - 06/2006
7	Pick Disease of the Brain (Pick's Disease) 12/2022 - 06/2002
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2009
6	Sporadic Creutzfeldt-Jakob Disease 01/2021 - 06/2003
6	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2015 - 02/2004
5	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 01/2019
5	Sarcoma (Soft Tissue Sarcoma) 04/2014 - 07/2010
4	TDP-43 Proteinopathies 01/2023 - 12/2013
3	Proteostasis Deficiencies 01/2024 - 04/2014
3	Chronic Traumatic Encephalopathy 01/2023 - 01/2020
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 03/2005
3	Amyloid Plaque 05/2021 - 04/2015
3	Amyloidosis 01/2017 - 10/2008
3	Neuroinflammatory Diseases 01/2017 - 09/2011
3	Multiple System Atrophy 12/2013 - 03/2004
2	Craniocerebral Trauma (Head Injury) 11/2023 - 01/2019
2	Schizophrenia (Dementia Praecox) 02/2023 - 01/2018
2	Tuberous Sclerosis (Bourneville's Disease) 01/2023 - 01/2020
2	Neurobehavioral Manifestations 01/2023 - 02/2016
2	Epilepsy (Aura) 01/2023 - 09/2013
2	COVID-19 12/2022 - 01/2021
2	Memory Disorders (Memory Loss) 01/2022 - 01/2018
2	Pathologic Processes 12/2021 - 02/2019
2	Prodromal Symptoms 01/2021 - 02/2015
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 12/2019 - 12/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2015
2	Insulin Resistance 01/2018 - 02/2015
2	Seizures (Absence Seizure) 01/2017 - 09/2013

Drug/Important Bio-Agent (IBA)

66	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2006
58	Amyloid (Amyloid Fibrils)IBA 03/2024 - 10/2008
44	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
34	ProgranulinsIBA 01/2023 - 03/2007
26	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2023 - 06/2008
23	Apolipoproteins E (ApoE)IBA 12/2023 - 05/2006
14	tau Proteins (tau Protein)IBA 03/2024 - 06/2002
13	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2023 - 02/2017
11	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2023 - 05/2010
11	ApolipoproteinsIBA 01/2022 - 05/2006
10	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 10/2008
7	Amyloid beta-PeptidesIBA 01/2023 - 02/2010
7	UbiquitinIBA 12/2017 - 06/2005
6	TESIBA 04/2024 - 01/2019
6	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2011
6	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2008
5	Butylated Hydroxyanisole (BHA)IBA 01/2024 - 01/2018
5	AntibodiesIBA 01/2023 - 06/2002
5	Apolipoprotein E4IBA 01/2021 - 02/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2008
5	PrionsIBA 01/2017 - 07/2006
4	Protein AggregatesIBA 10/2023 - 04/2014
4	Protein Isoforms (Isoforms)IBA 01/2023 - 06/2002
4	LipidsIBA 01/2023 - 01/2019
4	alpha-SynucleinIBA 01/2023 - 03/2004
4	Complement System Proteins (Complement)IBA 02/2022 - 07/2010
4	Prion ProteinsIBA 10/2015 - 02/2004
3	Glial Fibrillary Acidic ProteinIBA 08/2023 - 01/2020
3	Threonine (L-Threonine)FDA Link 01/2023 - 02/2015
3	Memantine (Namenda)FDA Link 01/2022 - 07/2009
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 04/2010
3	Retinaldehyde (Retinal)IBA 01/2022 - 09/2014
3	FluorineIBA 01/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 01/2020 - 12/2016
3	Insulin (Novolin)FDA Link 01/2018 - 02/2014
3	RNA-Binding Protein FUSIBA 05/2013 - 07/2010
2	TabletsIBA 01/2024 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2023 - 07/2011
2	Cathepsin DIBA 01/2023 - 07/2015
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2019
2	lysosomal proteinsIBA 01/2023 - 07/2015
2	Peptides (Polypeptides)IBA 12/2021 - 11/2016
2	Levetiracetam (Keppra)FDA LinkGeneric 11/2021 - 09/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2005
2	GranulinsIBA 01/2021 - 06/2015
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2020 - 09/2014
2	EnzymesIBA 12/2019 - 09/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019 - 05/2010
2	LigandsIBA 01/2019 - 11/2018
2	CholesterolIBA 01/2019 - 01/2019
2	Biological FactorsIBA 01/2019 - 01/2006
2	HDL LipoproteinsIBA 01/2019 - 07/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 09/2012
2	AD 20 (AD-20)IBA 01/2018 - 02/2015
2	ChemokinesIBA 03/2017 - 01/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2016

Therapy/Procedure

23	Therapeutics 01/2024 - 11/2007
2	Long-Term Care 01/2021 - 11/2003